General Safety & Performance Requirements (GSPRs)
Table of Contents
Introduction
The General Safety & Performance Requirements (GSPRs) are a set of essential regulatory requirements governing the safety and performance of medical devices and in-vitro diagnostic devices in compliance with European Union regulations. These requirements are mandated under the Medical Devices Regulation (EU MDR 2017/745) and the In Vitro Diagnostic Medical Devices Regulation (EU IVDR 2017/746), ensuring product safety, quality, and efficacy in healthcare applications.
Definitions and Concepts
The GSPRs serve as a cornerstone of EU MDR and IVDR compliance, comprising three key elements:
- General Requirements: Covering safety aspects such as design, manufacturing processes, and risk management strategies.
- Performance Requirements: Pertaining to the functionality, reliability, and clinical efficacy of the medical or diagnostic device.
- Risk Management: A systematic approach ensuring hazards are identified, evaluated, and mitigated throughout the product lifecycle.
Other relevant concepts include clinical evidence, post-market surveillance, and quality management systems, all integrated into the framework to meet GSPRs.
Importance
The GSPRs are pivotal in ensuring the safety and effectiveness of medical and in-vitro diagnostic devices used within the European Union. Their importance lies in:
- Providing a unified regulatory framework that harmonizes product standards across member states.
- Minimizing the risks associated with device use, thereby protecting patient and user health.
- Promoting trust and reliability in medical advancements by compelling manufacturers to maintain high standards for safety and performance.
- Facilitating access to the European market for compliant devices, ensuring a competitive and standardized industry environment.
Principles or Methods
The implementation of GSPRs relies on the following principles and methodologies:
- Risk-Based Approach: Manufacturers must demonstrate risk reduction to as low as possible through design and manufacturing processes, with justifiable residual risks.
- Clinical Evidence: Devices must be backed by robust clinical data validating safety and performance, obtained through clinical investigations or literature review.
- Usability Engineering: Emphasizing user-centric design to limit use errors and enhance safety through clear instructions and interfaces.
- Post-Market Surveillance (PMS): Monitoring product performance through vigilance systems and ensuring continued compliance with GSPRs throughout the device lifecycle.
- International Standards: Using harmonized standards such as ISO 14971 for risk management, IEC 60601 for electrical safety, and others to meet GSPR documentation requirements.
Application
In the life sciences, pharmaceutical, and biotech industries, GSPRs are operationalized through various stages of device development and regulatory compliance:
- Design and Development: Ensuring product safety and performance considerations are integrated from conception through prototyping.
- Pre-Market Approval: Demonstrating compliance with GSPRs as part of the technical documentation submitted to notified bodies for CE marking.
- Manufacturing and Quality Control: Implementing a quality management system (QMS) like ISO 13485 that ensures consistent compliance during production.
- Clinical Investigations: Conducting trials or studies to gather evidence supporting the device’s conformity with GSPRs.
- Market Surveillance: Ensuring ongoing GSPR adherence through adverse event reporting, trend analysis, and field safety corrective actions.
These applications enable manufacturers to ensure their devices meet legal obligations and maintain safety and efficacy standards over time.